Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
AssigneeBristol-Myers Squibb Company
InventorMichel Chazard
Life of this patent
Estimating the term…
Abstract
This invention provides a dosage form and a method of administering an anti-tumor composition comprising tegafur, uracil and folinic acid to potentiate the coadministration of oxaliplatin.
Claims9
A method for the synergistic treatment of cancer which comprises orally administering a synergistically effective amount of tegafur, uracil, and folinic acid or a pharmaceutically acceptable salt thereof to a mammal undergoing treatment with oxaliplatin.
A method for the synergistic treatment of cancer which comprises orally administering a synergistically effective amount of UFT and folinic acid or a pharmaceutically acceptable salt thereof to a mammal undergoing treatment with oxaliplatin.
Dependencies are inferred from the claim text.